Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 23;2(4):e001106.
doi: 10.1136/bmjopen-2012-001106. Print 2012.

Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure

Jonathan D Tung  1 , Ali Tafreshi, Robert N Weinreb, J Rigby Slight, Felipe A Medeiros, John H K Liu
Affiliations

Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure

Jonathan D Tung et al. BMJ Open. .

Abstract

Objectives: To investigate the 24 h effects of bimatoprost 0.01% monotherapy on intraocular pressure (IOP) and ocular perfusion pressure (OPP).

Design: Prospective, open-label experimental study.

Setting: Single tertiary ophthalmic clinic.

Participants: Sixteen patients with diagnosed primary open-angle glaucoma (POAG) or ocular hypertension (ages, 49-77 years).

Interventions: Baseline data of 24 h IOP in untreated patients were collected in a sleep laboratory. Measurements of IOP were taken using a pneumatonometer every 2 h in the sitting and supine body positions during the 16 h diurnal/wake period and in the supine position during the 8 h nocturnal/sleep period. After baseline measurements were taken, patients were treated with bimatoprost 0.01% one time per day at bedtime for 4 weeks, and then 24 h IOP data were collected under the same laboratory conditions.

Primary and secondary outcome measures: Diurnal and nocturnal IOP and OPP means under bimatoprost 0.01% treatment were compared with baseline.

Results: The diurnal and nocturnal IOP means were significantly lower under the bimatoprost 0.01% treatment than baseline in both the sitting and supine positions. The diurnal and nocturnal OPP means were significantly higher under treatment than baseline in both the sitting and supine positions.

Conclusion: Bimatoprost 0.01% monotherapy significantly lowered IOP and increased OPP during the 24 h period.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Profiles of 24 h IOP in the habitual body positions. Measurements were taken from 16 subjects sitting during the diurnal period and supine during the nocturnal period. Open circles represent the baseline, and solid circles represent the bimatoprost 0.01% treatment for 4 weeks. Error bars represent standard error of the mean. IOP, intraocular pressure.
Figure 2
Figure 2
Profiles of 24 h supine IOP. Open circles represent the baseline, and solid circles represent the bimatoprost 0.01% treatment for 4 weeks. Data were from the same 16 subjects as in figure 1. Error bars represent standard error of the mean. IOP, intraocular pressure.
See this image and copyright information in PMC

References

    1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet 2004;363:1711–20 - PubMed
    1. Weinreb RN, Harris A. Ocular blood flow in Glaucoma. WGA consensus series 6. Amsterdam, the Netherlands: Kugler Publications, 2009:59–128
    1. Medeiros FA, Brandt J, Liu J, et al. IOP as a risk factor for glaucoma development and progression. In: Weinreb RN, Brandt JD, Garway-Heath DF, et al. Intraocular pressure: reports and consensus statements of the 4th Global AIGS Consensus meeting on intraocular pressure. The Hague, The Netherlands: Kugler, 2007:59–74 WGA Consensus Series 4
    1. Bagga H, Liu JH, Weinreb RN. Intraocular pressure measurements throughout the 24 h. Curr Opin Ophthalmol 2009;20:79–83 - PubMed
    1. Orzalesi N, Rossetti L, Invernizzi T, et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000;41:2566–73 - PubMed